Publication Date

2015

Journal Title

J Clin Psychiatry

Abstract

OBJECTIVE: To compare outcomes after 6-month maintenance treatment of adults diagnosed with obsessive-compulsive disorder (OCD) based on DSM-IV criteria who responded to acute treatment with serotonin reuptake inhibitors (SRIs) augmented by exposure and response prevention (EX/RP) or risperidone. METHOD: A randomized trial was conducted at 2 academic sites from January 2007 through December 2012. In the acute phase, 100 patients on therapeutic SRI dose with at least moderate OCD severity were randomized to 8 weeks of EX/RP, risperidone, or pill placebo. Responders entered the 6-month maintenance phase, continuing the augmentation strategy they received acutely (n = 30 EX/RP, n = 8 risperidone). Independent evaluations were conducted every month. The main outcome was the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). RESULTS: Intent-to-treat analyses indicated that, after 6-month maintenance treatment, EX/RP yielded OCD outcomes that were superior to risperidone (Y-BOCS = 10.95 vs 18.70; t40 = 2.76, P = .009); more patients randomized to EX/RP met response criteria (Y-BOCS decrease >/= 25%: 70% vs 20%; P < .001) and achieved minimal symptoms (Y-BOCS

Volume Number

76

Issue Number

4

Pages

440-6

Document Type

Article

EPub Date

2014/11/07

Status

Faculty

Facility

School of Medicine

Primary Department

Psychiatry

PMID

25375780

DOI

10.4088/JCP.14m09044


Included in

Psychiatry Commons

Share

COinS